BSX
BOSTON SCIENTIFIC CORPCompliant · 81/100
Sector: Healthcare · Industry: Medical Devices · Data as of 2026-02-17
- Interest income not separately disclosed in filings; assumed immaterial (cash+securities / market cap = 1.5% < 20%).
Screening standard
The evidence
| Test | Figure | Limit | Source |
|---|---|---|---|
| Passed: Business activityBusiness activity is compliant. | compliant | ||
| Passed: Debt vs. market capinterest-bearing debt / market cap = 3.01% (< 33% limit). | 3.01% | < 33.00% | |
| Passed: Interest income vs. revenueInterest income not separately disclosed; assumed immaterial (cash+securities / market cap = 1.5% < 20% threshold). | compliant | ||
| Passed: Cash & interest-bearing assets vs. market cap(cash + interest-bearing securities) / market cap = 1.55% (< 33% limit). | 1.55% | < 33.00% |
Every number, sourced
Figures read directly from SEC EDGAR XBRL facts. Don't trust us — verify.
| Figure | Value | Source |
|---|---|---|
| Total revenueRevenue from contract with customer excluding assessed tax | $20.1B | |
| Interest-bearing debtLong term debt | $3.8B | |
| Cash & interest-bearing securitiesCash and cash equivalents at carrying value | $2.0B | |
| Total assetsAssets | $43.7B | |
| Shares outstandingEntity common stock shares outstanding | 1.5B shares | |
| Priceyahoo:24mo-trailing-avg | $85.408 |
Price
Values & Controversies
Separate from the shariah verdict above — always.
No flags. This company isn't on the BNC (Boycott National Committee) priority or divestment lists, or any grassroots BDS-supported campaign we line.